Weighted Linear Regression Analysis of BRI and ASM/BMI. حسب Wei Huang (36889)

Enrichment analysis of genes from the significant MS module. حسب Lai Jiang (2401513)

الموضوعات:

JP4-039 decreases mitochondrial ROS in human coronary artery endothelial cells <i>in vitro.</i> حسب Rayane Brinck Teixeira (6676529)

Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023. حسب Heba Tallah Mohammed (2822432)

الموضوعات:

Comparison of the Non-healed but Improved PIs Based on Initial Wound Area Size in 2022 vs. 2023. حسب Heba Tallah Mohammed (2822432)

الموضوعات:

Multivariate linear regression analysis of scales. حسب Xiangyu Wang (341093)

Voxel-based whole-hemisphere analysis shows regional and dose-dependent decrease of microglia. حسب Francesca Catto (21253435)

Compression modulus of improved red clay at 1600 kPa. حسب Quan Shen (37564)

الموضوعات:

Compressive strain of improved red clay at 1600 kPa. حسب Quan Shen (37564)

الموضوعات:

<i>e-lgp</i> curve of improved red clay. حسب Quan Shen (37564)

الموضوعات:

Univariate linear regression analysis of scales. حسب Xiangyu Wang (341093)

Forest plot of the second endpoint of the clinical symptom improvement. حسب Jin-Min Gu (17915039)

الموضوعات:

BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma. حسب Zahra Motahari (6814013)

الموضوعات:

Factors associated with the hemoglobin level stratified by age group: Linear regression. حسب Alejandro Rojas Chaves (20614814)

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"